Bernd Müller-Beckmann has more than 30 years experience in pharmaceutical industry where he held various scientific and managerial positions in the field of preclinical drug research & development and clinical development. Until recently he was the coordinator for preclinical safety at Roche’s Pharmaceutical Research and Development Center in Penzberg, Germany. Prior to this assignment he served as Global Coordinator for Biopharmaceuticals Safety at F. Hoffmann-La Roche Ltd., Basel, Switzerland. Under his leadership a company guideline for the non-clinical safety evaluation of biopharmaceuticals was developed, now a globally harmonized internal standard reference. In earlier roles as scientist and Head of Pharmacology & Toxicology he was involved and contributed to the discovery, preclinical and clinical development of a number of novel small molecules and biologics for various therapeutic areas, i.e. oncology, bone metabolism, diabetes, lipid metabolism and cardiovascular diseases. Bernd Müller Beckmann studied veterinary medicine at the universities of Berlin and Giessen. He holds a Ph.D. from the university of Giessen and is a board certified specialist for pharmacology and toxicology.